Seminars in Nuclear Medicine

Papers
(The median citation count of Seminars in Nuclear Medicine is 5. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-06-01 to 2025-06-01.)
ArticleCitations
Theranostics in Lung Neuroendocrine Tumors115
Letter from the Guest Editors110
Letter from the Editors94
Imaging of Invasive Fungal Infections- The Role of PET/CT63
Non-FDG hypoxia tracers54
Highlighting New Research Trends on Zirconium-89 Radiopharmaceuticals Beyond Antibodies51
Neurological Disorders and Women's Health: Contribution of Molecular Neuroimaging Techniques49
Sentinel Lymph Node Methods in Breast Cancer46
Radioimmunotherapy of Non-Hodgkin B-cell Lymphoma: An update41
PET/CT in the Imaging of CNS Tumors41
FAPI-PET in Cardiovascular Disease40
Controversies in the Radioiodine Treatment of Patients With Differentiated Thyroid Cancer38
Autoimmune Thyroid Diseases38
Artificial Intelligence for Drug Discovery: An Update and Future Prospects36
The Role of Nuclear Medicine in Benign Thyroid Disease34
Imaging for Radiation Planning in Breast Cancer34
Molecular Imaging in Inflammatory Bowel Disease34
Selective Internal Radiotherapy in Liver Tumors: Early Promise Yet to be Fulfilled33
Global experience in brain amyloid imaging32
Pediatric Nephro-Urology: Overview and Updates in Diuretic Renal Scans and Renal Cortical Scintigraphy32
Prognostic Value of PSMA PET/CT in Prostate Cancer32
Total-Body PET/CT: A Role of Artificial Intelligence?29
The Evolution of Artificial Intelligence in Nuclear Medicine29
Emerging Trends in Radionuclide Imaging of Infection and Inflammation in Pediatrics: Focus on FDG PET/CT and Immune Reactivity29
Radionuclide Imaging of Cardiac Amyloidosis: An Update and Future Aspects28
Variants and Pitfalls in PET/CT Imaging of Gastrointestinal Cancers28
FDG PET/CT for Detection of Infectious Complications Following Solid Organ Transplantation26
Remote Reading and Teaching of Nuclear Medicine in the Era of COVID-1925
Current and Future Perspective of PET/CT in Response Assessment of Malignant Pleural Mesothelioma25
PET/MR Technology: Advancement and Challenges24
The Role of 18-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography (18F-FDG PET/CT) in the Diagnosis and Evaluation of Spondylodiscitis23
Artificial intelligence for tumor [18F]FDG-PET imaging: Advancement and future trends—part I23
New Approaches for Imaging Bacteria23
Imaging of Cardiac Sarcoidosis: An Update and Future Aspects23
Expanding Role for Gallium-68 PET Imaging in Oncology23
Letter from the Guest Editors22
Letter From the Editors22
18F-Fluoride PET/CT—Updates21
Total Body Positron Emission Tomography/Computed Tomography: Current Status in Oncology21
Standardized PSMA-PET Imaging of Advanced Prostate Cancer20
Use of Radionuclide-Based Imaging Methods in Breast Cancer20
Scintigraphic Diagnosis of Acute Pulmonary Embolism: From Basics to Best Practices20
Update on Pediatric Nuclear Medicine in Acute Care19
Total-body PET/CT – First Clinical Experiences and Future Perspectives19
Impact of COVID-19 on Nuclear Medicine in Asia19
Fibroblast Activation Protein Inhibitor (FAPI) PET Imaging in Sarcomas: A New Frontier in Nuclear Medicine19
Letter from the Editors18
Practice of 18F-FDG-PET/CT in ICU Patients: A Systematic Review18
18F-Sodium Fluoride PET/CT in Assessing Valvular Heart and Atherosclerotic Diseases17
Radiolabeled Somatostatin Analogs for Cancer Imaging17
FDG PET/CT for Staging Lung Carcinoma: An Update17
Future Imaging of Prostate Cancer: Do We Need More Than PSMA PET/CT?16
Diagnosis and Image-guided Therapy of Cardiac Left Ventricular Assist Device Infections16
FAPI PET Versus FDG PET/CT in Gastrointestinal Cancers: An Overview16
Nuclear Medicine Preclinical Research: The Role of Cell Cultures16
Optimizing CT Imaging Parameters: Implications for Diagnostic Accuracy in Nuclear Medicine15
Safe Pulmonary Scintigraphy in the Era of COVID-1915
Functional Imaging of Testicular Torsion15
The Impact of PSMA PET/CT Imaging in Prostate Cancer Radiation Treatment15
Targeted Radiopharmaceutical Therapy for Bone Metastases15
The Clinical Utility of Molecular Imaging in COVID-19: An Update15
Advances in PET Imaging of Large Vessel Vasculitis: An Update and Future Trends15
Artificial Intelligence Augmented Cerebral Nuclear Imaging14
Application of Artificial Intelligence in Oncologic Molecular PET-Imaging: A Narrative Review on Beyond [18F]F-FDG Tracers Part II. [F]F-FLT, [F]F-FET, [C]C-MET and Other Less-Commonly Used Radiotrace14
FDG-PET/CT Variants and Pitfalls in Haematological Malignancies14
Academic integrity and artificial intelligence: is ChatGPT hype, hero or heresy?14
The Impact of COVID-19 on Nuclear Medicine in Europe14
Artificial Intelligence and Workforce Diversity in Nuclear Medicine14
Molecular Imaging for Response Assessment of Neuroendocrine Tumors (NET)14
Recent Advances in Radiopharmaceutical Theranostics of Pheochromocytoma and Paraganglioma14
Molecular Imaging in Soft-tissue Sarcoma: Evolving Role of FDG PET14
PET/CT Variants and Pitfalls in Prostate Cancer: What You Might See on PET and Should Never Forget13
Quantitative SPECT/CT for Dosimetry of Peptide Receptor Radionuclide Therapy13
FDG-PET/CT of COVID-19 and Other Lung Infections13
Letter from the Editors13
Radiomics and Artificial Intelligence Landscape for [18F]FDG PET/CT in Multiple Myeloma13
Prostate Cancer Theranostics With 177Lu-PSMA13
Telehealth in Multidisciplinary Target Delineation for Radiotherapy During the COVID-19 Pandemic. A Review and a Case13
Radiomolecular Theranostics With Fibroblast-Activation-Protein Inhibitors and Peptides13
Imaging in Renal Transplants: An Update12
Letter From the Guest Editors12
Infection and Inflammation in Nuclear Medicine Imaging: The Role of Artificial Intelligence12
PET/CT Variants and Pitfalls in Gynecological Cancers12
A Role of Non-FDG Tracers in Lung Cancer?12
COVID-19 Pandemic: What Have We Learned and What to Expect in the Future?12
A Practical Guide to the Pearls and Pitfalls of PSMA PET Imaging12
PET Assessment of Cardiac Allograft Vasculopathy12
Letter From the Editors12
Radiation Dose to Pediatric Patients From Radiopharmaceuticals12
How to Perform FAPI PET? An Expedited Systematic Review Providing a Recommendation for FAPI PET Imaging With Different FAPI Tracers12
Hybrid Imaging: Calcium Score and Myocardial Perfusion Imaging11
Cardiac PET/MRI: Recent Developments and Future Aspects11
Advances in PET/CT Technology: An Update11
Total Body PET/CT: A Role in Musculoskeletal Diseases11
Pitfalls on PET/MRI11
Letter from the Editors11
Letter From the Editors10
Parathyroid Imaging10
Towards a More Inclusive Future: A Comprehensive Assessment of Gender Diversity in Nuclear Medicine Education, Training and Workforce10
Advances of PET/CT in Target Delineation of Lung Cancer Before Radiation Therapy10
SPECT/CT, PET/CT, and PET/MRI for Response Assessment of Bone Metastases10
Copper-64 Based PET-Radiopharmaceuticals: Ways to Clinical Translational10
Letter from the Editors10
Preclinical Evaluation of Novel PET Probes for Dementia10
Cardiovascular Imaging in Women10
PET/CT Assessment of Estrogen Receptor positivity for Breast Cancer using [68Ga]Ga-RM2 Bombesin Receptor Antagonist: A Systematic Review and Meta-Analysis9
Diagnosing Bone Metastases in Breast Cancer: A Systematic Review and Network Meta-Analysis on Diagnostic Test Accuracy Studies of 2-[18F]FDG-PET/CT, 18F-NaF-PET/CT, MRI, Contrast-Enhanced CT, and Bone9
Letter from the Editors9
PET/CT Variants and Pitfalls in Breast Cancers9
Dosimetric Approaches for Radioimmunotherapy of Non-Hodgkin Lymphoma in Myeloablative Setting9
FDG PET/CT for Staging and Restaging Malignant Mesothelioma9
The Value of Artificial Intelligence in Prostate-Specific Membrane Antigen Positron Emission Tomography: An Update9
Clinical Management of COVID-19 Patients – An Update9
Long Axial Field-of-View PET/CT: New Opportunities for Pediatric Imaging9
New PET Tracers: Current Knowledge and Perspectives in Lung Cancer9
PET/CT Variants and Pitfalls in Bone and Soft Tissue Sarcoma9
New Targets for Imaging in Nuclear Medicine9
Molecular imaging Theranostics of Neuroendocrine Tumors8
Current and Future Perspectives of PDL1 PET and SPECT Imaging8
Letter from the Editors8
Imaging Approach to Disease of the Pleura8
Pitfalls of Radionuclide Renal Imaging in Pediatrics8
Advancement and Future Perspective of FAPI PET/CT In Gynecological Malignancies8
AI in SPECT Imaging: Opportunities and Challenges8
Letter from the Editors8
The Past, Present, and Future Role of Artificial Intelligence in Ventilation/Perfusion Scintigraphy: A Systematic Review8
Hepato-Biliary Imaging in an Acute Setting: Is There a Role for Nuclear Medicine?8
Imaging of Endocarditis and Cardiac Device-Related Infections: An Update8
Imaging of Bone Metastases in Breast Cancer8
The Rebirth of Radioimmunotherapy of Non-Hodgkin Lymphoma: The Phoenix of Nuclear Medicine?8
Application of Artificial Intelligence in Oncologic Molecular PET-Imaging: A Narrative Review on Beyond [18F]F-FDG Tracers - Part I. PSMA, Choline, and DOTA Radiotracers7
The Role of FDG-PET and Whole-Body MRI in High Grade Bone Sarcomas With Particular Focus on Osteosarcoma7
FDG PET/CT Imaging of Sarcoidosis7
FDG PET for Assessment of Autologous Stem Cell Transplantation7
Critical Appraisal of the Current Role of Myocardial Perfusion Imaging in the Management of Acute Chest Pain7
Letter From the Editors7
Advancement in Production of Radiotracers7
Combination Strategies and Targeted Radionuclide Therapies7
Imaging of Cardiac Transplantation: An Overview7
Practical Considerations When Interpreting FDG PET/CT Imaging for Staging and Treatment Response Assessment in Melanoma Patients7
The Current Role of Tau PET Imaging in Neurodegeneration7
Diagnostic Value of Gastrin-Releasing Peptide Receptor-Targeted PET Imaging in Oncology: A Systematic Review7
Advances in PSMA Alpha Theragnostics7
Preclinical Development in Radiopharmaceutical Therapy for Prostate Cancer7
Application of Deep Learning in Breast Cancer Imaging7
Letter From the Editors7
Artificial Intelligence in Nuclear Cardiology: An Update and Future Trends7
Letter from the Editors7
PET/CT in Bladder Cancer: An Update6
Molecular Imaging of Tuberculosis6
Clinical Use of PET/MR in Oncology: An Update6
PET/CT Variants and Pitfalls in Liver, Biliary Tract, Gallbladder and Pancreas6
Long Axial Field-of-View (LAFOV) PET/CT in Prostate Cancer6
Preclinical Imaging Studies: Protocols, Preparation, Anesthesia, and Animal Care6
Role of Artificial Intelligence in PET/CT Imaging for Management of Lymphoma6
18F-FDG PET/CT for Evaluation of Post-Transplant Lymphoproliferative Disorder (PTLD)6
FDG-PET/CT for Primary Staging and Detection of Recurrence of Breast Cancer6
Bone Metastasis in Prostate Cancer: Bone Scan Versus PET Imaging6
The Role of [18F]FDG PET/CT in Monitoring of Therapy Response in Lung Cancer5
Molecular Imaging of Fever of Unknown Origin: An Update5
The Impact of Radiopharmaceutical Therapy on Renal Function5
PET Imaging in Neurodegeneration and Neuro-oncology: Variants and Pitfalls5
18F-FDG PET/CT for Response Assessment in Lung Cancer5
Diuretic Renal Scintigraphy in Adults: Practical Aspects and Reporting5
Clinical Value of FDG-PET/CT in Multiple Myeloma: An Update5
Total Body PET-CT Protocols in Oncology5
The Role of AI in the Evaluation of Neuroendocrine Tumors: Current State of the Art5
A Role for PET/CT in Response Assessment of Malignant Pleural Mesothelioma5
0.074495077133179